Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression
Clinical Trial Grant
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Bristol-Myers Squibb Company
Start Date
October 1, 2014
End Date
September 30, 2017
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Bristol-Myers Squibb Company
Start Date
October 1, 2014
End Date
September 30, 2017